Increasing prevalence of chronic diseases driving the demand for advanced tissue diagnostic procedures is expected to propel the growth of the microtome market. Technological advancements leading to the development of automated and precision microtomes are also contributing to market growth. Moreover, rising investments in research and development activities in the healthcare sector are creating lucrative growth opportunities for the market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Technology |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Diapath S.P.A., Leica Biosystems Nussloch, Sakura Finetek Europe B.V., MEDITE, SLEE medical, Boeckeler Instruments, Nanolytik, S.M. Scientific Instruments Pvt.., AGD Biomedicals, Alltion, Amos Scientific Pvt.., Thermo Fisher Scientific |
High cost associated with advanced microtomes and lack of skilled professionals for operating these instruments are major restraints hindering the growth of the microtome market. Additionally, stringent regulatory requirements for the approval of microtomes in different regions are posing challenges for market players.